Kantonsspital St.Gallen
login

SILENT 2

Peter Ammann, Georg Kägi, Michaela Gemperle & Roman Brenner

abstract

Incidence of Silent Atrial Fibrillation in Patients With Clinically Silent Brain Ischemic Lesions

Arterial Fibrillation (AF) is well-recognized as a cause for cryptogenic Acute Ischemic Stroke (AIS) and is associated with Silent Brain Infarction (SBI). However, the role of AF in the formation of lesions (SBIs) is less well established than its role in AIS and needs clarification.

The investigators hypothesize that continuous rhythm monitoring will yield a similar incidence of AF diagnosis in patients with SBI as compared to patients with cryptogenic AIS.

The primary objective is to assess the cumulative incidence of AF diagnosis at 24 months in patients with SBI.
   
project homepage http://https://clinicaltrials.gov/ct2/show/NCT04449523
project partner Inselspital Bern Kardiologie
KSSG Neurologie
type of project clinical studies
status ongoing - recruiting phase
start of project 2020
study design Prospective Observational Cohort
responsible person Peter Ammann, Georg Kägi